Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

James Suen

Concepts (310)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arteriovenous Malformations
9
2018
66
1.690
 Why?
Head and Neck Neoplasms
14
2012
336
1.350
 Why?
Carcinoma, Squamous Cell
12
2011
385
0.920
 Why?
Neck
7
2018
116
0.760
 Why?
Vascular Malformations
3
2010
101
0.710
 Why?
Head
5
2018
78
0.680
 Why?
Patients
1
2018
53
0.630
 Why?
Terminal Care
1
2018
55
0.620
 Why?
Hemangioma
3
2018
83
0.600
 Why?
Laryngectomy
3
2013
28
0.580
 Why?
Attitude to Health
1
2018
226
0.570
 Why?
Laryngeal Neoplasms
2
2007
55
0.540
 Why?
Carcinoma, Merkel Cell
4
2016
47
0.500
 Why?
Laser Therapy
3
2011
91
0.490
 Why?
Quality of Life
3
2012
922
0.480
 Why?
Laryngeal Diseases
1
2013
14
0.450
 Why?
Herpes Simplex
1
2013
24
0.440
 Why?
Parotid Diseases
1
2012
4
0.440
 Why?
Neuromuscular Agents
1
2012
7
0.440
 Why?
Nuclear Proteins
6
2015
253
0.440
 Why?
Botulinum Toxins, Type A
1
2012
14
0.440
 Why?
Leukoplakia, Oral
1
2011
8
0.420
 Why?
Aminolevulinic Acid
1
2011
10
0.420
 Why?
Lasers, Dye
1
2011
10
0.410
 Why?
Eating
1
2012
163
0.410
 Why?
Photosensitizing Agents
1
2011
24
0.410
 Why?
Photochemotherapy
1
2011
37
0.400
 Why?
Survivors
1
2012
137
0.400
 Why?
Cheek
1
2010
9
0.370
 Why?
Lip
1
2010
11
0.370
 Why?
Female
29
2018
28457
0.360
 Why?
Flow Cytometry
6
2019
547
0.360
 Why?
Facial Neoplasms
1
2010
23
0.360
 Why?
Neoplastic Cells, Circulating
4
2019
92
0.360
 Why?
Humans
48
2019
54304
0.360
 Why?
Receptors, Progesterone
1
2009
57
0.350
 Why?
Middle Aged
20
2018
13076
0.350
 Why?
Pain
1
2012
404
0.350
 Why?
Male
29
2018
27335
0.350
 Why?
Lymphatic Vessels
1
2009
49
0.340
 Why?
Aged
16
2018
10054
0.340
 Why?
Postoperative Complications
3
2012
1035
0.340
 Why?
Adult
20
2017
14189
0.320
 Why?
Skin Neoplasms
4
2016
532
0.320
 Why?
Recurrent Laryngeal Nerve
1
2007
20
0.320
 Why?
Laryngeal Nerves
1
2007
19
0.320
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1060
0.310
 Why?
Surgical Flaps
1
2009
135
0.310
 Why?
Neoplasms
1
2018
1321
0.310
 Why?
Factor VII
1
2007
3
0.300
 Why?
Melanoma
2
2022
313
0.300
 Why?
Intracranial Arteriovenous Malformations
1
2007
28
0.300
 Why?
Dilatation
2
2017
27
0.290
 Why?
Gene Silencing
4
2009
129
0.250
 Why?
Disease Models, Animal
3
2016
1651
0.240
 Why?
Adolescent
10
2012
6896
0.230
 Why?
Cell Proliferation
4
2016
1097
0.220
 Why?
Melanoma, Experimental
2
2016
49
0.220
 Why?
Retrospective Studies
10
2015
6462
0.220
 Why?
Muscarinic Agonists
1
2002
12
0.220
 Why?
Xerostomia
1
2002
3
0.220
 Why?
Immunohistochemistry
8
2014
1090
0.220
 Why?
Sjogren's Syndrome
1
2002
14
0.210
 Why?
Endoscopy
2
2015
131
0.210
 Why?
Thiophenes
1
2002
37
0.210
 Why?
Plasmodium yoelii
1
2022
17
0.210
 Why?
Nitric Oxide Synthase Type III
2
2013
84
0.210
 Why?
Quinuclidines
1
2002
42
0.210
 Why?
Treatment Outcome
7
2018
5609
0.210
 Why?
Promoter Regions, Genetic
7
2015
520
0.210
 Why?
Malaria
1
2022
37
0.210
 Why?
Veins
3
2010
74
0.200
 Why?
Azepines
3
2016
22
0.200
 Why?
Embolization, Therapeutic
3
2011
98
0.190
 Why?
Transcription Factors
2
2015
622
0.190
 Why?
Triazoles
3
2016
119
0.180
 Why?
Child
10
2012
7372
0.170
 Why?
Neoplasm Invasiveness
3
2010
294
0.170
 Why?
Child, Preschool
8
2012
4161
0.170
 Why?
Mast Cells
1
2018
64
0.160
 Why?
Ki-67 Antigen
3
2013
63
0.160
 Why?
Cricoid Cartilage
1
2017
11
0.160
 Why?
Combined Modality Therapy
4
2018
693
0.150
 Why?
Mice
10
2022
6428
0.150
 Why?
Estradiol
1
2018
219
0.150
 Why?
Trachea
1
2017
51
0.150
 Why?
Mice, Nude
5
2016
284
0.150
 Why?
Lasers, Semiconductor
2
2022
10
0.140
 Why?
Qualitative Research
1
2018
325
0.140
 Why?
Embolism
1
2016
27
0.140
 Why?
Follow-Up Studies
3
2011
2389
0.140
 Why?
Benzoxazoles
1
2016
12
0.140
 Why?
Infant
7
2018
3832
0.140
 Why?
Biopsy
3
2015
693
0.140
 Why?
Matrix Metalloproteinase 2
1
2016
64
0.140
 Why?
Neoplasm Staging
2
2010
805
0.140
 Why?
Matrix Metalloproteinase 9
1
2016
93
0.140
 Why?
Tracheotomy
1
2015
14
0.140
 Why?
Tracheal Stenosis
1
2015
10
0.140
 Why?
Laryngostenosis
1
2015
10
0.130
 Why?
TOR Serine-Threonine Kinases
1
2016
85
0.130
 Why?
Proto-Oncogene Proteins c-myb
1
2015
9
0.130
 Why?
Photoacoustic Techniques
1
2016
86
0.130
 Why?
Aged, 80 and over
6
2015
3430
0.130
 Why?
Larynx
2
2017
39
0.130
 Why?
Proto-Oncogene Proteins c-myc
1
2014
55
0.120
 Why?
Pyrimidines
1
2016
196
0.120
 Why?
Fluorouracil
2
2004
61
0.120
 Why?
Disease Progression
3
2014
915
0.120
 Why?
DNA Methylation
5
2009
575
0.120
 Why?
Carcinoma
2
2012
154
0.120
 Why?
Gene Expression Regulation, Neoplastic
3
2015
868
0.120
 Why?
Breast Neoplasms
2
2015
1248
0.110
 Why?
Mastication
1
2012
7
0.110
 Why?
Trismus
1
2012
4
0.110
 Why?
Apoptosis
2
2016
1302
0.110
 Why?
Adaptor Proteins, Signal Transducing
3
2009
208
0.110
 Why?
Radiotherapy, Adjuvant
1
2012
66
0.110
 Why?
Animals
10
2022
14402
0.110
 Why?
DNA, Neoplasm
2
2011
171
0.110
 Why?
Receptors, Cell Surface
1
2013
130
0.110
 Why?
Recurrence
2
2011
692
0.110
 Why?
Lymphangioma, Cystic
1
2011
9
0.100
 Why?
Chemoradiotherapy
1
2012
42
0.100
 Why?
Endothelium, Lymphatic
1
2011
13
0.100
 Why?
Cisplatin
2
2004
351
0.100
 Why?
Syndrome
1
2012
253
0.100
 Why?
Administration, Topical
1
2011
71
0.100
 Why?
Enteral Nutrition
1
2012
135
0.100
 Why?
Epigenesis, Genetic
1
2015
399
0.100
 Why?
Antigens, CD
1
2013
242
0.100
 Why?
Lymphatic Abnormalities
1
2011
22
0.100
 Why?
Propranolol
1
2012
78
0.100
 Why?
Deglutition Disorders
1
2012
72
0.100
 Why?
Immunoenzyme Techniques
4
2016
166
0.100
 Why?
Microtubule-Associated Proteins
1
2011
78
0.100
 Why?
Homeodomain Proteins
1
2011
82
0.100
 Why?
Brain Neoplasms
1
2014
285
0.100
 Why?
Tumor Suppressor Proteins
1
2011
141
0.100
 Why?
Weight Gain
1
2012
241
0.100
 Why?
Epigenomics
1
2011
67
0.100
 Why?
Diagnosis, Differential
2
2011
1143
0.090
 Why?
Xenograft Model Antitumor Assays
3
2016
219
0.090
 Why?
Risk Assessment
1
2015
1361
0.090
 Why?
Lip Neoplasms
1
2010
4
0.090
 Why?
Diagnostic Imaging
1
2011
185
0.090
 Why?
Neoplastic Stem Cells
1
2011
104
0.090
 Why?
Neoplasm Recurrence, Local
2
2019
645
0.090
 Why?
Microsatellite Instability
1
2009
20
0.090
 Why?
Lasers, Solid-State
1
2010
32
0.090
 Why?
Neoadjuvant Therapy
1
2011
125
0.090
 Why?
Neoplasm Proteins
2
2003
360
0.090
 Why?
Melanins
1
2009
31
0.090
 Why?
Hospitals, Teaching
1
2010
58
0.090
 Why?
Medical Records
1
2010
92
0.090
 Why?
Mouth
1
2010
35
0.090
 Why?
Survival Rate
3
2011
954
0.090
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
6
0.090
 Why?
Vascular Surgical Procedures
1
2011
178
0.090
 Why?
Carcinoma, Medullary
1
2009
15
0.090
 Why?
Proto-Oncogene Proteins c-ret
1
2009
35
0.090
 Why?
Receptors, Estrogen
1
2009
131
0.080
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
25
0.080
 Why?
Pilot Projects
1
2011
805
0.080
 Why?
Port-Wine Stain
1
2008
14
0.080
 Why?
Muscle, Smooth, Vascular
1
2009
140
0.080
 Why?
Immunotherapy
1
2011
264
0.080
 Why?
Early Detection of Cancer
2
2022
164
0.080
 Why?
Blotting, Western
3
2016
684
0.080
 Why?
Dose-Response Relationship, Drug
1
2011
1476
0.080
 Why?
Vascular Endothelial Growth Factor A
1
2008
233
0.080
 Why?
Tumor Cells, Cultured
3
2016
477
0.080
 Why?
Cytokines
1
2011
677
0.080
 Why?
Factor VIIa
1
2007
10
0.080
 Why?
Jaw Diseases
1
2007
7
0.080
 Why?
Thyroid Neoplasms
1
2009
162
0.070
 Why?
Practice Guidelines as Topic
1
2010
487
0.070
 Why?
Practice Management, Medical
1
2006
13
0.070
 Why?
Osteonecrosis
1
2007
36
0.070
 Why?
Postoperative Hemorrhage
1
2007
53
0.070
 Why?
Infant, Newborn
2
2011
2923
0.070
 Why?
Tongue
1
2007
41
0.070
 Why?
Bone Density Conservation Agents
1
2007
82
0.070
 Why?
Otolaryngology
1
2006
58
0.070
 Why?
Diphosphonates
1
2007
96
0.070
 Why?
Cell Line, Tumor
3
2015
1551
0.070
 Why?
Recombinant Proteins
1
2007
570
0.070
 Why?
Mice, Inbred NOD
2
2016
99
0.070
 Why?
Prospective Studies
1
2011
2604
0.060
 Why?
Mice, SCID
2
2016
196
0.060
 Why?
Skin
1
2008
468
0.060
 Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2004
10
0.060
 Why?
Neoplasm Metastasis
2
2015
252
0.060
 Why?
Ataxia Telangiectasia
1
2004
5
0.060
 Why?
DNA Repair Enzymes
1
2004
50
0.060
 Why?
Statistics, Nonparametric
1
2004
230
0.060
 Why?
Cross-Sectional Studies
2
2012
1693
0.060
 Why?
Genes, p16
1
2003
9
0.060
 Why?
Polymerase Chain Reaction
4
2009
531
0.060
 Why?
Lymph Node Excision
1
2004
140
0.060
 Why?
Proteoglycans
1
2003
96
0.060
 Why?
Radiotherapy
1
2004
137
0.060
 Why?
Magnetic Resonance Angiography
2
2018
80
0.060
 Why?
Antigens, Nuclear
2
2013
24
0.060
 Why?
Young Adult
2
2012
4313
0.060
 Why?
Transplantation, Heterologous
2
2013
76
0.060
 Why?
Magnetic Resonance Imaging
2
2007
1616
0.060
 Why?
Plasmodium falciparum
1
2022
18
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
674
0.050
 Why?
Erythrocytes
1
2022
98
0.050
 Why?
Membrane Glycoproteins
1
2003
270
0.050
 Why?
Double-Blind Method
1
2002
742
0.050
 Why?
Survival Analysis
3
2009
736
0.050
 Why?
Tryptases
1
2018
4
0.040
 Why?
Estrogen Receptor beta
1
2018
56
0.040
 Why?
Estrogen Receptor alpha
1
2018
95
0.040
 Why?
Arkansas
1
2004
2097
0.040
 Why?
Protein Transport
1
2018
195
0.040
 Why?
Ultrasonography, Doppler
1
2018
57
0.040
 Why?
Biopsy, Fine-Needle
2
2009
116
0.040
 Why?
Pressure
1
2017
120
0.040
 Why?
Cadaver
1
2017
113
0.040
 Why?
Serum
1
2016
39
0.030
 Why?
Molecular Imaging
1
2016
60
0.030
 Why?
Risk Factors
3
2015
3934
0.030
 Why?
Drug Synergism
1
2016
171
0.030
 Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
18
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2016
206
0.030
 Why?
Mammography
1
2015
96
0.030
 Why?
Acetylation
1
2015
99
0.030
 Why?
Keratin-20
1
2014
7
0.030
 Why?
Enhancer Elements, Genetic
1
2015
64
0.030
 Why?
G1 Phase Cell Cycle Checkpoints
1
2014
21
0.030
 Why?
Drug Therapy, Combination
1
2016
426
0.030
 Why?
Chromatin
1
2015
156
0.030
 Why?
Prognosis
3
2004
2126
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2013
37
0.030
 Why?
HEK293 Cells
1
2014
245
0.030
 Why?
Cell Cycle Proteins
1
2015
198
0.030
 Why?
Gene Expression Regulation
1
2018
1064
0.030
 Why?
Comorbidity
1
2015
666
0.030
 Why?
Down-Regulation
1
2014
388
0.030
 Why?
Protein Binding
1
2015
736
0.030
 Why?
Actins
1
2013
132
0.030
 Why?
RNA, Messenger
1
2016
1203
0.030
 Why?
Lymphocele
1
2011
7
0.030
 Why?
Base Sequence
2
2004
719
0.030
 Why?
Tissue Survival
1
2011
12
0.030
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
55
0.030
 Why?
Tissue Culture Techniques
1
2011
46
0.030
 Why?
Predictive Value of Tests
1
2014
1044
0.030
 Why?
Gluconates
1
2011
1
0.020
 Why?
Neoplasms, Squamous Cell
1
2011
9
0.020
 Why?
Cell Line
1
2014
1152
0.020
 Why?
Indomethacin
1
2011
40
0.020
 Why?
Graft Survival
1
2011
165
0.020
 Why?
Injections, Subcutaneous
1
2011
58
0.020
 Why?
Interleukin-2
1
2011
75
0.020
 Why?
Gene Expression Profiling
1
2016
1141
0.020
 Why?
Carrier Proteins
2
2003
360
0.020
 Why?
Interleukin-1beta
1
2011
92
0.020
 Why?
Cyclophosphamide
1
2011
172
0.020
 Why?
Interferon-gamma
1
2011
195
0.020
 Why?
Glottis
1
2010
32
0.020
 Why?
Drug Administration Schedule
1
2011
401
0.020
 Why?
Disease-Free Survival
1
2011
488
0.020
 Why?
Time Factors
2
2007
3207
0.020
 Why?
Sclerotherapy
1
2010
47
0.020
 Why?
Endothelial Cells
1
2011
294
0.020
 Why?
Calcitonin
1
2009
38
0.020
 Why?
Paraffin Embedding
1
2008
56
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2011
435
0.020
 Why?
Thyroidectomy
1
2009
103
0.020
 Why?
Mice, Transgenic
1
2009
658
0.020
 Why?
Dental Care
1
2007
11
0.020
 Why?
Mouth Floor
1
2007
5
0.020
 Why?
Polyvinyl Alcohol
1
2007
7
0.020
 Why?
Curettage
1
2007
15
0.020
 Why?
Signal Transduction
1
2014
1751
0.020
 Why?
Hyperbaric Oxygenation
1
2007
17
0.020
 Why?
Current Procedural Terminology
1
2006
9
0.020
 Why?
Pharyngeal Diseases
1
2007
12
0.020
 Why?
Collateral Circulation
1
2007
41
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Cutaneous Fistula
1
2007
16
0.020
 Why?
Neck Dissection
1
2007
43
0.020
 Why?
Office Visits
1
2006
48
0.020
 Why?
Fistula
1
2007
28
0.020
 Why?
Angiography
1
2007
148
0.020
 Why?
Salvage Therapy
1
2007
145
0.020
 Why?
Adrenal Cortex Hormones
1
2007
95
0.020
 Why?
Imidazoles
1
2007
143
0.020
 Why?
Genetic Predisposition to Disease
1
2009
571
0.020
 Why?
Preoperative Care
1
2007
184
0.020
 Why?
Ultrasonography
1
2006
486
0.020
 Why?
Guanine
1
2004
42
0.020
 Why?
United States
1
2015
5204
0.020
 Why?
Syndecans
1
2003
43
0.010
 Why?
Methylation
1
2004
130
0.010
 Why?
Syndecan-1
1
2003
82
0.010
 Why?
Base Pair Mismatch
1
2003
24
0.010
 Why?
DNA Adducts
1
2004
162
0.010
 Why?
Cell Count
1
2003
181
0.010
 Why?
Antineoplastic Agents
1
2011
1300
0.010
 Why?
DNA Repair
1
2003
203
0.010
 Why?
Alcohol Drinking
1
2003
259
0.010
 Why?
Molecular Sequence Data
1
2003
980
0.010
 Why?
Anti-Bacterial Agents
1
2007
825
0.010
 Why?
Smoking
1
2003
552
0.010
 Why?
Multiple Myeloma
1
2007
3049
0.010
 Why?
Suen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (310) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (27) people
_
Same Department Expand Description
Search Department